March 11, 2025
admin
(30 seconds reading)
Zydus Lifesciences announced on March 10, 2025, that it has entered exclusive negotiations to acquire an 86% majority stake in Amplitude Surgical for €256.8 million. The acquisition price represents an 80.6% premium over Amplitude’s last closing price and higher premiums over its 3- and 6-month averages. Amplitude Surgical, a European MedTech leader in lower-limb orthopedic technologies, reported €106 million in sales and €27.1 million in EBITDA for the fiscal year ending June 30, 2024. The acquisition aims to strengthen Zydus’s MedTech portfolio, expanding its presence in the orthopedic sector.
